Pharmaceutical Sciences Research

 

Pharmacology & Toxicology

 

Programmatic Research Goals and Objectives:

  • Develop and maintain an actively funded multispecialty research program focusing on mechanistic studies at the cellular and molecular level

  • Offer outstanding research training opportunities to professional Pharm.D. students to attract them into areas of pharmaceutical research

  • Promote the training and development of M.S., Ph.D., and post-Ph.D. scientists in pharmacology and toxicology

  • Expand our interdisciplinary program in drug discovery and preclinical evaluation

  • Provide local, regional, and national expertise in the areas of pharmacology and toxicology to assist state and local agencies and enhance private industry and opportunities for economic development

Faculty

Scott Burchiel, Ph.D. – effects of environmental agents and drugs on the human immune system, environmental carcinogenesis of breast cancer; biotechnology

Laurie Hudson, Ph.D. – regulation of epithelial plasticity in metastasis and wound repair, ovarian and skin cancer, mechanisms of arsenic carcinogenesis

Steve Peterson, Ph.D. – mechanisms of free radical-induced neuropathology in experimental models of epilepsy

Todd A. Thompson, Ph.D. - Application of pharmacogenomic and toxicogenomic methods to assess chemopreventive and therapeutic strategies for cancer.

Hugh Smyth, Ph.D. - Drug delivery, lung cancer, cystic fibrosis

Mary Walker, Ph.D. – function of the aryl hydrocarbon receptor (AhR) in cardiovascular development and physiology

 

 

The University of New Mexico’s Doctor of Pharmacy program is accredited by the Accreditation Council for Pharmacy Education, 20 North Clark Street, Suite 2500, Chicago, IL 60602-5109, TEL (312) 664-3575 , FAX (312) 664-4652, URL http://www.acpe-accredit.org/

05/07/2009 10:07:01 AM -0600.